Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multicenter, phase 2 study comparing Paclitaxel/Carboplatin
with or without bavituximab in patients that have previously untreated locally advanced or
metastatic non-small cell lung cancer (NSCLC).